We are live on ! Find out more
CGL

Clarius Group LLC Portfolio holdings

AUM $1.75B
1-Year Est. Return 19.04%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$214M
AUM Growth
+$26.9M
Cap. Flow
+$9.07M
Cap. Flow %
4.23%
Top 10 Hldgs %
70.16%
Holding
99
New
14
Increased
28
Reduced
43
Closed
5

Top Buys

Rank Stock Value
1
AGIO icon
Agios Pharmaceuticals
AGIO
+$2.68M
2
EDIT icon
Editas Medicine
EDIT
+$1.79M
3
PI icon
Impinj
PI
+$937K
4
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$620K
5
VIG icon
Vanguard Dividend Appreciation ETF
VIG
+$609K

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$646K
2
VSS icon
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
+$482K
3
MXPT
MaxPoint Interactive, Inc.
MXPT
+$318K
4
IBM icon
IBM
IBM
+$271K
5
CVS icon
CVS Health
CVS
+$210K

Sector Composition

Rank Sector Weight
1 Industrials 34.92%
2 Consumer Discretionary 15.73%
3 Healthcare 7.84%
4 Technology 5.27%
5 Communication Services 4.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TIP icon
76
iShares TIPS Bond ETF
TIP
$14.5B
$248K 0.12%
+2,128
New +$247K
V icon
77
Visa
V
$677B
$247K 0.12%
2,988
-444
-13% -$35.5K
MMM icon
78
3M
MMM
$91.8B
$245K 0.11%
1,665
+211
+15% +$31.5K
INTC icon
79
Intel
INTC
$413B
$244K 0.11%
6,478
-891
-12% -$31.6K
KO icon
80
Coca-Cola
KO
$383B
$238K 0.11%
5,591
-1,028
-16% -$45K
IJJ icon
81
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$230K 0.11%
3,466
-200
-5% -$13.2K
NVS icon
82
Novartis
NVS
$302B
$223K 0.1%
3,164
+20
+0.6% +$1.46K
CMS icon
83
CMS Energy
CMS
$23.3B
$219K 0.1%
5,213
+36
+0.7% +$1.57K
BMY icon
84
Bristol-Myers Squibb
BMY
$129B
$217K 0.1%
4,069
-1,881
-32% -$121K
UNP icon
85
Union Pacific
UNP
$174B
$201K 0.09%
2,063
-318
-13% -$29.7K
IXN icon
86
iShares Global Tech ETF
IXN
$7.87B
$188K 0.09%
+10,200
New +$180K
FIG
87
DELISTED
Fortress Investment Group Llc
FIG
$158K 0.07%
+32,036
New +$158K
PRFZ icon
88
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.74B
$129K 0.06%
20,350
– –
VWO icon
89
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$117K 0.05%
3,110
-490
-14% -$18.2K
CSLT
90
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$83K 0.04%
20,000
– –
PCO
91
DELISTED
Pendrell Corporation - Class A
PCO
$75K 0.04%
+108
New +$71.3K
UMC icon
92
United Microelectronic
UMC
$42.9B
$27K 0.01%
+14,554
New +$27.8K
CGEN icon
93
Compugen
CGEN
$212M
– –
-10,000
Closed -$65K
CVS icon
94
CVS Health
CVS
$135B
– –
-2,190
Closed -$210K
IBM icon
95
IBM
IBM
$213B
– –
-1,866
Closed -$271K
VSS icon
96
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11B
– –
-5,182
Closed -$482K
XOM icon
97
ExxonMobil
XOM
$650B
– –
-6,893
Closed -$646K
1 2 3
4

Similar funds

A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.57B AUM 25.73% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
NAS
Nicolet Advisory Services Green Bay, Wisconsin $1.48B AUM 17.28% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
LGWM
Litman Gregory Wealth Management Larkspur, California $1.37B AUM 16.95% 1-Year Est. Return

Clarius Group LLC's Q3 2016 Portfolio in Review

As of Q3 2016, Clarius Group LLC held 99 positions worth $214M, up 14% from $188M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Clarius Group LLC deployed $9.07M of net new capital in Q3 2016, opening 14 new positions and adding to 28 existing holdings. Its largest new stake was Editas Medicine: 87,231 shares worth $1.18M.

By sector, the portfolio is most concentrated in Industrials at 35% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was MaxPoint Interactive, Inc., an estimated $318K trimmed.

  • Clarius Group LLC's largest Q3 2016 buy was Editas Medicine: 87,231 shares worth $1.18M.
  • Clarius Group LLC added most to Agios Pharmaceuticals in Q3 2016, an estimated $2.68M increase.
  • Clarius Group LLC's biggest Q3 2016 reduction was MaxPoint Interactive, Inc., cutting an estimated $318K.
  • Clarius Group LLC fully exited ExxonMobil in Q3 2016, selling an estimated $646K.
  • Clarius Group LLC's ten largest holdings make up 70% of its $214M portfolio in Q3 2016.
  • Clarius Group LLC opened 14 new positions and closed 5 in Q3 2016.
  • Clarius Group LLC's portfolio value rose 14% quarter-over-quarter to $214M.

Based on Clarius Group LLC's 13F filing for Q3 2016, filed 14 Nov 2016.